Business
from24/7 Wall St.
1 week agoBristol Myers Just Crushed Earnings, and the Real Catalyst Hasn't Even Hit Yet
Bristol Myers delivered stable Q4 revenue driven by a 16% Growth Portfolio surge that offset steep Legacy Portfolio declines while guiding modestly lower 2026 revenue.